Weight loss drug Wegovy can reduce heart attack risk, study says
By Karah Rucker (Anchor/Reporter), Ben Burke (Editor), Brock Koller (Senior Producer)
Media Landscape
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this dataBias Distribution
Left
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests
Click to see story on The IndependentObesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Click to see story on BloombergWeight loss drug Wegovy cuts risk of heart problems, maker says
Click to see story on Star TribuneWegovy weight loss drug set for use on NHS also cuts heart attack and stroke risk, trial shows
Click to see story on iNewsWegovy reduces risk of heart attacks, strokes, and death by up to 20%, new study finds
Click to see story on INSIDERWeight loss drug Wegovy, results beyond expectations in an advanced clinical trial: reduces risk of cardiovascular disease by 20%
Click to see story on Hot NewsNovo’s weight-loss drug Wegovy cuts risk of heart disease by 20% – trial data
Click to see story on ReutersObesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
Click to see story on Hindustan TimesNovo Nordisk shares pop after key trial data shows Wegovy cuts risk of heart attack or stroke by 20%
Click to see story on CNBCWegovy: Weight loss injections can lower heart attack and stroke risk in obese people by a fifth, research suggests
Click to see story on Sky News UKWeight-Loss Drug Wegovy Lowers Major Heart Disease Risk By 20% According To Trial Data—Novo Nordisk Shares Surge
Click to see story on ForbesPopular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
Click to see story on FortuneNovo’s weight-loss drug Wegovy cuts risk of heart disease by 20% – trial data
Click to see story on DevdiscourseWegovy cuts heart attack and stroke risk, study shows
Click to see story on NY1INSTANT VIEW-Novo’s obesity drug cuts risk of heart disease by 20% in study
Click to see story on WTVBNovo Nordisk’s weight loss jab Wegovy cuts risk of stroke by 20%
Click to see story on Financial TimesNovo Nordisk hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20% By Investing.com
Click to see story on Investing.comWeight Loss Drug Wegovy May Help Prevent Heart Attacks
Click to see story on WebMDPopular weight loss drug Wegovy also found to lower the risk of heart attacks, strokes
Click to see story on Good Morning AmericaNovo’s obesity drug Wegovy lowers cardiovascular risk by 20%, landmark trial finds
Click to see story on STATWeight loss drug Wegovy can reduce heart attack risk, study says
Click to see story on Straight Arrow NewsWeight loss jab ‘cuts risk of heart attacks and strokes’
Click to see story on The TelegraphWeight-loss drug Wegovy cuts heart attack risk in people with obesity, study shows
Click to see story on National PostWeight-loss drug Wegovy cuts heart attack, stroke risk by 20%, study shows
Click to see story on Alabama LiveWeight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Click to see story on Wall Street JournalNovo Nordisk weight loss drug Wegovy cuts heart disease risk by 20%, trial shows
Click to see story on Fox BusinessRight
Untracked Bias
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests
Click to see story on Shropshire StarStudy: Wegovy drug reduces risk of heart disease by 20 percent
Click to see story on handelsblatt.comWegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Click to see story on Het NieuwsbladWegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Click to see story on Het Belang van LimburgWeight loss drug Wegovy found to lower risk of heart attack, stroke
Click to see story on Western Iowa Today 96.5 KSOM KS 95.7Wegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Click to see story on Gazet van AntwerpenNovo Nordisk Says Weight-Loss Drug Cuts Risk of Cardiovascular Events
Click to see story on Morningstar.comStudy: Wegovy slimming injection reduces risk of heart disease by 20 percent
Click to see story on Salzburger NachrichtenThe weight loss drug Wegovy has become wildly popular, and the health benefits go beyond just dropping pounds, according to new data released by the drugmaker. Results of the clinical trial released on Tuesday, Aug. 8, suggests the supplement, used for quickly losing weight, directly coincides with a lower risk of heart disease by as much as 20%.
The study, which has not been peer-reviewed, suggests people taking Wegovy have cut their risk of experiencing a heart attack or a stroke by one-fifth. That’s a higher reduction than what many health experts had originally predicted.
Unbiased news.
Directly to your inbox. Free!
Learn more about our emails. Unsubscribe anytime.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
The clinical trials lasted more than five years and studied more than 17,000 patients who were overweight or obese with heart disease taking Wegovy or a placebo.
Now that the results are in, the Danish drugmaker Novo Nordisk wants to capitalize on the results by looking to add cardiovascular benefits to the drug’s prescribing label. If that happens, there’s a higher chance insurance companies would provide more coverage for the weight loss pills that typically cost more than $1,300 a month.
Ozempic, the Type 2 diabetes injection that has become a popular weight loss drug lowered cardiovascular risk by 26%, according to a clinical trial solely for diabetics. Ozempic has not been approved by the FDA as a weight loss drug.
A study published by the National Institute for Health and Care Research says obesity raises the risk of heart disease by at least 28%.
While the Wegovy clinical trial points to promising results of lowering heart disease, the No. 1 killer in the U.S., there have also been health concerns posed by the government over taking the pills.
Straight Arrow News reported in July about an investigation into the potential link between the drug and stomach paralysis.
THE WEIGHT LOSS DRUG WEGOVY HAS BECOME WILDLY POPULAR —
AND THE HEALTH BENEFITS GO BEYOND JUST DROPPING POUNDS ACCORDING TO NEW DATA.
A TRIAL-STUDY NOW SUGGESTS THE SUPPLEMENT FOR LOSING WEIGHT FAST DIRECTLY COINCIDES WITH A LOWER RISK OF HEART DISEASE —
BY AS MUCH AS **20 PERCENT**.
THE STUDY SUGGESTS PEOPLE TAKING WEGOVY HAVE CUT THEIR RISK OF SUFFERING A HEART ATTACK OR A STROKE BY ONE-FIFTH.
THAT’S A HIGHER REDUCTION THAN WHAT MANY HEALTH EXPERTS HAD ORIGINALLY PREDICTED.
THE CLINICAL TRIALS LASTED MORE THAN FIVE YEARS AND STUDIED MORE THAN 17 THOUSAND PATIENTS WHO WERE OVERWEIGHT OR OBESE WITH HEART DISEASE TAKING WEGOVY OR A PLACEBO.
NOW THAT THE RESULTS ARE IN –
PARENT COMPANY “NOVO NORDISK” WANTS TO CAPITALIZE ON THE RESULTS —
LOOKING TO ADD CARDIOVASCULAR BENEFITS TO THE DRUG’S PRESCRIBING LABEL.
IF THAT HAPPENS — THERE’S A HIGHER CHANCE **INSURANCE COMPANIES** WOULD PROVIDE MORE COVERAGE FOR THE WEIGHT LOSS PILLS THAT TYPICALLY COST MORE THAN 13 HUNDRED DOLLARS A MONTH.
WHILE THE STUDY HASN’T YET BEEN PEER-REVIEWED —
THE RESULTS MAKE SENSE.
OBESITY RAISES YOUR RISK OF HEART DISEASE BY AT LEAST **28 PERCENT —
ACCORDING TO A STUDY PUBLISHED BY THE “NATIONAL INSTITUTE FOR HEALTH AND CARE RESEARCH.”
SO IF BY TAKING WEGOVY, PATIENTS ARE REACHING A HEALTHIER WEIGHT — THEN THAT LOWERS THE HIGH RISK LEVELS ASSOCIATED WITH OBESITY.
THE OTHER POPULAR WEIGHT-LOSS AND DIABETES DRUG OZEMPIC LOWERED CARDIOVASCULAR RISK BY 26 PERCENT — ACCORDING TO A CLINICAL TRIAL SOLELY FOR DIABETICS.
WHILE THE WEGOVY CLINICAL TRIAL POINTS TO PROMISING RESULTS OF LOWERING HEART DISEASE — THE NUMBER ONE KILLER IN THE U.S. —
THERE HAVE ALSO BEEN HEALTH **CONCERNS POSED BY THE GOVERNMENT OVER TAKING THE PILLS – INCLUDING A POTENTIAL LINK TO STOMACH PARALYSIS.
YOU CAN FIND THAT REPORT ON OUR WEBSITE S-A-N DOT COM.
Media Landscape
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this dataBias Distribution
Left
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests
Click to see story on The IndependentObesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Click to see story on BloombergWeight loss drug Wegovy cuts risk of heart problems, maker says
Click to see story on Star TribuneWegovy weight loss drug set for use on NHS also cuts heart attack and stroke risk, trial shows
Click to see story on iNewsWegovy reduces risk of heart attacks, strokes, and death by up to 20%, new study finds
Click to see story on INSIDERWeight loss drug Wegovy, results beyond expectations in an advanced clinical trial: reduces risk of cardiovascular disease by 20%
Click to see story on Hot NewsNovo’s weight-loss drug Wegovy cuts risk of heart disease by 20% – trial data
Click to see story on ReutersObesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
Click to see story on Hindustan TimesNovo Nordisk shares pop after key trial data shows Wegovy cuts risk of heart attack or stroke by 20%
Click to see story on CNBCWegovy: Weight loss injections can lower heart attack and stroke risk in obese people by a fifth, research suggests
Click to see story on Sky News UKWeight-Loss Drug Wegovy Lowers Major Heart Disease Risk By 20% According To Trial Data—Novo Nordisk Shares Surge
Click to see story on ForbesPopular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
Click to see story on FortuneNovo’s weight-loss drug Wegovy cuts risk of heart disease by 20% – trial data
Click to see story on DevdiscourseWegovy cuts heart attack and stroke risk, study shows
Click to see story on NY1INSTANT VIEW-Novo’s obesity drug cuts risk of heart disease by 20% in study
Click to see story on WTVBNovo Nordisk’s weight loss jab Wegovy cuts risk of stroke by 20%
Click to see story on Financial TimesNovo Nordisk hits record highs as study shows Wegovy treatment cut the risk of heart issues by 20% By Investing.com
Click to see story on Investing.comWeight Loss Drug Wegovy May Help Prevent Heart Attacks
Click to see story on WebMDPopular weight loss drug Wegovy also found to lower the risk of heart attacks, strokes
Click to see story on Good Morning AmericaNovo’s obesity drug Wegovy lowers cardiovascular risk by 20%, landmark trial finds
Click to see story on STATWeight loss drug Wegovy can reduce heart attack risk, study says
Click to see story on Straight Arrow NewsWeight loss jab ‘cuts risk of heart attacks and strokes’
Click to see story on The TelegraphWeight-loss drug Wegovy cuts heart attack risk in people with obesity, study shows
Click to see story on National PostWeight-loss drug Wegovy cuts heart attack, stroke risk by 20%, study shows
Click to see story on Alabama LiveWeight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Click to see story on Wall Street JournalNovo Nordisk weight loss drug Wegovy cuts heart disease risk by 20%, trial shows
Click to see story on Fox BusinessRight
Untracked Bias
Weight loss jabs can cut risk of heart attack or stroke by fifth, study suggests
Click to see story on Shropshire StarStudy: Wegovy drug reduces risk of heart disease by 20 percent
Click to see story on handelsblatt.comWegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Click to see story on Het NieuwsbladWegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Click to see story on Het Belang van LimburgWeight loss drug Wegovy found to lower risk of heart attack, stroke
Click to see story on Western Iowa Today 96.5 KSOM KS 95.7Wegovy slimming drug also reduces risk of strokes and heart attacks, says producer
Click to see story on Gazet van AntwerpenNovo Nordisk Says Weight-Loss Drug Cuts Risk of Cardiovascular Events
Click to see story on Morningstar.comStudy: Wegovy slimming injection reduces risk of heart disease by 20 percent
Click to see story on Salzburger NachrichtenStraight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
MOST POPULAR
-
John Fetterman joins Truth Social, backs Trump cabinet picks
Watch 3:1617 hrs ago -
Mark Zuckerberg’s Meta spends $1 million to mend fences with Trump
Watch 4:1017 hrs ago -
Bill would force Big Health Care to sell pharmacies within 3 years
Watch 7:5118 hrs ago -
Former FBI informant pleads guilty to lying about $10M Biden family bribe
Watch 1:4418 hrs ago